The overall objectives of the ERA PerMed call are (i) to support translational research projects in the field of Personalised Medicine; (ii) to encourage interdisciplinary collaboration between academia (research teams from universities, higher education institutions, public research performing institutions), clinical/public health research (research teams from hospital/ public health institutions, healthcare settings and other healthcare organisations) and private partners e.g. SMEs (small and medium-size enterprises).
This call for proposals includes 28 research funding organisations from the following 21 countries and 5 regions: Austria (decision on participation still pending), Belgium, Croatia, Denmark, Finland, France, Estonia, Germany (Saxony), Hungary, Ireland, Israel, Italy (Lombardy, Tuscany), Latvia, Luxembourg, Norway, Panama, Poland, Romania, Spain (Catalonia, Navarre), Sweden and Turkey. The available budget for this call is 16 Mio€ (approx.).
Proposals must be interdisciplinary and clearly demonstrate the potential impact on PM as well as the added value of transnational collaboration.
The JTC2021 is constructed around the following three research areas in order to ensure the development of specific PM approaches, taking into account the major aspects for their successful implementation in the health systems: (1) “Translating basic to clinical research and beyond”, (2) “Data and Information and Communication Technology (ICT)” and (3) “Research towards responsible implementation in Health Care”:
Each proposal MUST address the modules 1B “Clinical Research”, 2 “Towards application in health care” and 3B “Ethical, Legal and Social Aspects”. The inclusion of modules 1A “Pre-clinical research” and 3A “Health Economic Research” is optional. Their added value to the proposal and the mandatory modules has to be clearly described.
Joint research proposals may be submitted by applicants belonging to one of the following categories (A, B and/or C), if eligible according to relevant regional/national funding organisations’ regulations for research funding:
A. Academia or research institutes;
B. Clinical/public health sector;
C. (Industry) Private partners, e.g. SMEs (small and medium-size enterprises).
Only transnational projects will be funded. Each consortium submitting a proposal must involve at least three partners eligible for funding coming from three different countries whose funders participate in the call. All three legal entities must be independent of each other. At least two partners of the minimum three eligible project partners of the consortium must be from two different EU Member States or Associated Countries. The coordinator must be eligible to be funded by the participating funding organisations to this call. The maximum number of partners per project is six though not more than 2 eligible partners from the same country participating in the call will be accepted in one consortium (including those partners with own funding).
Research groups not eligible for funding (e.g. from non-funding countries or not fundable according to regional/national regulations of the participating funding organisation) may participate in transnational projects if they are able to secure their own funding. They are considered as full partners and have to be integrated in the pre- and full-proposal templates as such. No more than one partner with own funding is allowed in consortia with at least 3 partners that are eligible for funding.
At the full-proposal stage, a consortium might be increased up to seven partners in total only by inclusion of a partner coming from an underrepresented country. A list of underrepresented countries will be provided to coordinators invited for full-proposals submission.
The call is likely to be launched on December 14, 2020 with a submission deadline for pre-proposals on March 4, 2021. It is expected that the consortia invited for the full-proposal stage, will need to submit their proposal on June 16, 2021.
The information provided in this pre-announcement is indicative and may be subject to changes and is not legally binding for the indicated funding organisations. Additional funding organisations might join the call before the official publication.
Final call information is expected to be published on the ERA PerMed and ANR website by December 2020.
For more information: http://www.erapermed.eu/pre-announcement-jtc-2021/